MyFinsight
Home
Blog
About
Contact
Download
Download image
Net comprehensive
loss
-$148,277K
(0.41%↑ Y/Y)
Net loss
-$148,125K
(0.66%↑ Y/Y)
Net unrealized
(loss) gain on...
-$152K
(-167.56%↓ Y/Y)
Benefit from income
taxes
-$550K
(-6011.11%↓ Y/Y)
Net loss before
benefit from income...
-$148,675K
(0.29%↑ Y/Y)
US
$9,478K
(2.24%↑ Y/Y)
Non Us
$1,681K
(132.18%↑ Y/Y)
Loss from operations
-$148,344K
(10.97%↑ Y/Y)
Total other (expense)
income
-$331K
(-101.89%↓ Y/Y)
Licensing and
collaboration revenue...
$11,159K
(11.66%↑ Y/Y)
Other income, net
$8,827K
(-42.49%↓ Y/Y)
Total operating
expenses
$159,503K
(-9.69%↓ Y/Y)
Impairment of equity method
investment
-$9,158K
Research and development
$109,439K
(-15.92%↓ Y/Y)
General and
administrative
$37,914K
(-18.39%↓ Y/Y)
Impairment charges
$12,150K
Back
Back
Income Statement
source: myfinsight.com
Caribou Biosciences, Inc. (CRBU)
Caribou Biosciences, Inc. (CRBU)